India's Serum Institute to get $150 million from Gates Foundation for COVID-19 vaccine
Follow The Hawk on Google News+ FollowAdvertisement

BENGALURU: Serum Institute of India said on Friday it would receive $150 million in funding from the Bill & Melinda Gates Foundation and the GAVI vaccines alliance to make 100 million COVID-19 vaccine doses for India and other emerging economies as early as 2021.
The candidate vaccines, including those from AstraZeneca and Novavax, will be priced at $3 per dose and will be made available in 92 countries in GAVI's COVAX Advance Market Commitment (AMC), the company said in a statement.
Advertisement
The Gates Foundation will provide the funds to GAVI, which will be used to support Serum Institute.
Also readFSSAI to initiate action against Bisleri over unsafe water sample
GAVI, backed by the Gates Foundation, is a public–private global health partnership with the goal of increasing access to immunization in poor countries.
It co-leads COVAX - a scheme designed to guarantee fast and equitable access globally to COVID-19 vaccines - along with the World Health Organization and the Coalition for Epidemic Preparedness Innovations (CEPI).
Advertisement
COVAX aims to deliver 2 billion doses of approved and effective COVID-19 vaccines by the end of 2021.
India reported a record jump in daily coronavirus infections on Friday and became the third country in the world to surpass 2 million cases. It lags only the United States and Brazil in the number of infections. —Reuters
Get The Hawk first on Google
Add The Hawk as a preferred source and Google shows you more of our stories in Top Stories. Follow us on Google News too.
Advertisement








